Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Biosimilar Matches Aflibercept for Diabetic Macular Edema
TOPLINE: A biosimilar demonstrated comparable efficacy and safety to aflibercept in treating diabetic macular edema. The vascular endothelial growth factor (VEGF) inhibitor was one of two aflibercept biosimilars approved by the US Food and Drug Administration in May. METHODOLOGY: Researchers…
English